AQ4N
Showing 26 - 50 of >10,000
Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell
Active, not recruiting
- Stage I Lung Non-Small Cell Cancer AJCC v7
- +6 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Oct 24, 2022
Tumors Trial in Beijing ([68Ga]N188)
Recruiting
- Neoplasms
-
Beijing, Beijing, ChinaPeking University First Hospital
Jan 27, 2023
Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma Trial in Philadelphia (Capecitabine,
Active, not recruiting
- Anal Basaloid Carcinoma
- +6 more
- Capecitabine
- +6 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jan 3, 2023
ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial
Recruiting
- ENSAT Stage I Adrenal Cortex Carcinoma
- +2 more
- Cisplatin
- +3 more
-
Ann Arbor, Michigan
- +3 more
Dec 13, 2022
Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic
Terminated
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2022
Kidney Transplant Trial (Myreptic-N Tablet, Mycophenolate mofetil Tablet/Capsule)
Not yet recruiting
- Kidney Transplant
- Myreptic-N Tablet
- Mycophenolate mofetil Tablet/Capsule
- (no location specified)
Sep 13, 2023
Hypertension, Dyslipidemia Trial in Canada, United Kingdom (Amlodipine/Atorvastatin)
Completed
- Hypertension
- Dyslipidemia
-
Calgary, Alberta, Canada
- +125 more
Jan 26, 2021
Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)
Not yet recruiting
- Bipolar Disorder
- Cannabidiol
- Placebo
-
Calgary, Alberta, Canada
- +7 more
May 18, 2023
![](/image/sponsor/federal_budgetary_research_institution_state_research_center_of_virology_and_biotechnology_"vector")
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,
Completed
- Smallpox
- +3 more
- NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
- +5 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023
Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)
Active, not recruiting
- Blastoid Variant Mantle Cell Lymphoma
- +3 more
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Bronchiectasis, Non-Tuberculous Mycobacterial Pneumonia Trial in Calgary
Recruiting
- Bronchiectasis
- Non-Tuberculous Mycobacterial Pneumonia
-
Calgary, Alberta, CanadaUniversity of Calgary
Nov 17, 2023
Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in
Active, not recruiting
- Stage I Mantle Cell Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Buffalo, New York
- +1 more
Mar 9, 2022
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023
Depression in Adolescence Trial in Calgary (Pharmacogenetic-guided dosing, GLAD-PC guided dosing)
Not yet recruiting
- Depression in Adolescence
- Pharmacogenetic-guided dosing
- GLAD-PC guided dosing
-
Calgary, Alberta, CanadaUniversity of Calgary
Jul 25, 2023
Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Tumor, Fibrolamellar Carcinoma Trial in Worldwide (drug, other,
Recruiting
- Childhood Hepatocellular Carcinoma
- +4 more
- Carboplatin
- +12 more
-
Birmingham, Alabama
- +201 more
Jan 30, 2023
Hexoskin Medical System - ECG Performance Testing
Recruiting
- Cardiac Rhythm Disturbance
- Hexoskin Medical System
-
Toronto, Ontario, Canada
- +1 more
Aug 1, 2023
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
Parkinson's Disease and Parkinsonism Trial in Calgary (Tailored Support Group)
Not yet recruiting
- Parkinson's Disease and Parkinsonism
- Tailored Support Group
-
Calgary, Alberta, CanadaHealth Science Centre, University of Calgary
Oct 10, 2023
Testosterone and Vascular Function in Reproductive-Aged Females
Completed
- Chronic Kidney Diseases
- Cardiovascular Diseases
-
Calgary, Alberta, CanadaUniversity of Calgary
Oct 24, 2023
Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- 2 cycles induction chemotherapy
- 3 cycles induction chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaFirst Affiliated Hospital, Sun Yat-Sen University
May 6, 2023
Chronic Low-back Pain Trial (Psilocybin therapy with Zolpidem and Modafinil, Psilocybin therapy with Zolpidem, Psilocybin
Not yet recruiting
- Chronic Low-back Pain
- Psilocybin therapy with Zolpidem and Modafinil
- +3 more
- (no location specified)
Apr 27, 2022
Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)
Recruiting
- Neuroblastoma
- Radiopharmaceutical 68Ga-DOTATATE
-
Montréal, Quebec, Canada
- +2 more
Jan 3, 2023
Multiple Sclerosis Trial in Calgary (SIMBA Capsule)
Not yet recruiting
- Multiple Sclerosis
- SIMBA Capsule
-
Calgary, Alberta, CanadaUniversity of Calgary
Apr 25, 2023